Jeevan Scientific Technology Limited concluded its 28th Annual General Meeting on September 25, 2026, with all eight proposed resolutions passing with the requisite majority. The meeting was conducted through Video Conferencing and Other Audio-Visual Means in compliance with regulatory guidelines.

Key Resolutions Passed

The shareholders approved the adoption of the standalone and consolidated audited financial statements for FY26. Additionally, the meeting addressed several governance matters, including the reappointment of directors retiring by rotation and the continuation of executive leadership beyond statutory age limits.

Governance and Leadership Changes

The AGM ratified the reappointment of Snigdha Mothukuri and Nageswar Rao Yarlagadda as Whole Time Directors. A specific special resolution was passed to approve the continuation of Mr. Yarlagadda as Whole Time Director beyond the age of 70 years. The board also saw changes in its independent director composition with the reappointment of Suryaprakasa Rao Bommisetti and the appointment of Kolli Srinivas Rao.

Voting Participation Details

A total of 82 members attended the meeting through video conferencing, comprising 4 promoters and 78 public shareholders. The voting process was supervised by M/s. Aakanksha Dubey & Co., Practicing Company Secretaries, who served as the scrutinizer. The e-voting window was open from September 22 to September 24, 2026, prior to the live meeting.

What the Numbers Show

Voting results indicate strong promoter support, with promoters casting 4,590,385 votes in favor across all resolutions. Public non-institutional shareholders voted 579,032 shares, with a marginal dissent of 902 votes against certain director reappointments (Resolutions 2, 3, 4, 7, and 8), representing less than 0.16% of the public votes polled. Notably, Resolutions 1, 5, and 6 received 100% support from both promoter and public categories, suggesting minimal opposition from minority shareholders regarding the board's structural changes and financial approvals.

Jeevan Scientific Technology reported a significant turnaround in profitability for the first quarter of FY27, with standalone net profit rising to ₹188.60 lakh from a net loss of ₹215.99 lakh in Q1FY26. Consolidated net profit also improved, reaching ₹86.97 lakh, up 68.7% year-on-year from a loss of ₹126.22 lakh.

The Hyderabad-based clinical research services company saw its standalone revenue from operations decline 8.4% quarter-on-quarter to ₹1,693.47 lakh, though it remained 106.1% higher than the ₹821.57 lakh recorded in Q1FY25. Consolidated revenue fell 14.1% QoQ to ₹1,827.75 lakh but surged 81.7% YoY compared to ₹1,005.79 lakh in the prior year period.

Financial Performance

The company’s operational efficiency improved alongside the profit turnaround. Standalone other expenses decreased significantly to ₹676.85 lakh from ₹845.64 lakh in the preceding quarter, contributing to the bottom-line recovery despite a slight dip in top-line sales. Employee benefit expenses remained stable at ₹494.67 lakh, including ₹14.05 lakh towards ESOP expenses.

On a consolidated basis, the group benefited from lower inventory changes and controlled employee costs, which stood at ₹44.09 lakh. However, finance costs increased to ₹170.27 lakh from ₹177.08 lakh in the prior year, reflecting ongoing debt servicing obligations. The share of profit from associates remained negligible at a loss of ₹0.69 lakh.

What the Numbers Show

A key divergence exists between the standalone and consolidated results. While the standalone entity posted a robust net profit margin of approximately 11.1%, the consolidated group’s margin was thinner at roughly 4.7%. This spread is primarily driven by the performance of subsidiaries and associates, notably Nayas Laboratories Private Limited, which reported a net loss of ₹100.94 lakh for the quarter according to the auditor’s review report. This indicates that while the core clinical research operations are profitable, subsidiary investments continue to weigh on group-level profitability.

Corporate Actions

During its meeting on August 13, 2026, the Board of Directors approved several key administrative and governance matters:

• Re-appointment of Mrs. Snigdha Mothukuri as Whole Time Director for three years effective November 2, 2026.
• Continuation and re-appointment of Mr. Nageswar Rao Yarllagadda as Whole Time Director beyond age 70, effective June 23, 2027.
• Appointment of Mr. Kolli Srinivas Rao as an additional Independent Director effective immediately.
• Scheduling of the Annual General Meeting for FY26 on September 25, 2026, via video conferencing.

Pavuluri & Co., the statutory auditors, issued a limited review report on the interim financial results, stating that nothing came to their attention to cause them to believe the statements contained material misstatements.